This process ensures that P-selectin level assessments provide critical insights into the severity of the disease, allowing for healthcare professionals to make informed decisions and provide appropriate care to people affected by COVID-19 variants, thus avoiding thrombosis complications. This evidence concerns the gene SELP and deep vein thrombosis.